Pacific Edge rights offer mopped up by institutions, says underwriter
Postal delays hit Pacific Edge's rights issue, which was two-thirds subscribed.
Calida Smylie Tue, 07 Jul 2015
Biomedical company Pacific Edge’s [NZX: PEB] renounceable rights offer closed two-thirds subscribed but the underwriter says the remaining shares have been mopped up by institutional investors.
Shareholders affected by a postal delay, just announced by Pacific Edge to the NZX, will still receive
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).